Todas las investigaciones
CompletadoPhase IVIntervencionista

Antidepressants to prevent relapse in depression

Depression is a common mental health condition that causes low mood, poor sleep, and low energy. In the UK, millions of people take antidepressants, and many stay on them for years to stop their symptoms coming back. However, doctors are still unsure if taking them for this long is truly necessary once someone feels better. This study tests whether staying on antidepressants long-term actually prevents depression from returning. Researchers invited adults aged 18 to 74 who had taken one of four common antidepressants for at least nine months and felt ready to consider stopping. Participants were placed by chance into two groups. One group stayed on their regular medicine for a year. The other group reduced their dose over four weeks, then switched to a dummy pill (placebo). Both groups filled in regular surveys to track their mood and see how they got on.

De un vistazo

Estado
Completado
Fase
Phase IV
Patrocinador
PRIMENT CTU, University College London
Objetivo de inscripción
479
Inicio
01 Mar 2017
Estimación de finalización
28 Feb 2019

¿De qué trata este estudio?

Depression can make daily life very tough, causing feelings of sadness, exhaustion, and a loss of interest in things you normally enjoy. Antidepressants are widely prescribed to help ease these symptoms by balancing natural chemicals in the brain. For many people, these medicines provide vital support when they are unwell.

In the UK, health guidelines often suggest that people at risk of becoming unwell again should keep taking antidepressants for up to two years. Because of this, thousands of people stay on repeat prescriptions even after they have felt happy and healthy for months. However, there is surprisingly little scientific evidence showing whether staying on these medicines long-term actually stops depression from returning.

This clinical trial, run by University College London, was designed to find answers. Researchers wanted to compare what happens when people stay on their medication versus what happens when they carefully stop taking it. By following participants over a full year, the study aims to give GPs and patients the clear evidence they need to make safe, informed choices about when to stop treatment.

Puntos clave

  • Tests whether staying on antidepressants long-term really stops depression from returning.
  • Aimed at adults who have been on medication for at least 9 months and feel ready to consider stopping.
  • Participants either stay on their usual pill or slowly switch to a dummy pill (placebo).
  • Lasts for one year with regular questionnaires to check on mood and well-being.
  • Taking part is voluntary, and participants can return to standard care at any time.

¿Quién puede ser elegible?

This trial was designed for adults aged 18 to 74 who have had at least two episodes of depression in the past. To join, people needed to have been taking a standard dose of citalopram, sertraline, fluoxetine, or mirtazapine for at least nine months, and they had to feel well enough that they would consider stopping their medication.

People could not take part if they were currently experiencing an episode of depression, or if they had other mental health conditions such as bipolar disorder or psychosis. It was also not suitable for people with dementia, a terminal illness, or women who were pregnant, planning a pregnancy, or breastfeeding.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. I am between 18 and 74 years old.
  2. I have had at least two episodes of depression in the past.
  3. I have taken citalopram, sertraline, fluoxetine, or mirtazapine for at least 9 months.
  4. I currently feel well enough to think about coming off my antidepressant.
  5. I am not currently pregnant, planning to become pregnant, or breastfeeding.
  6. I do not have bipolar disorder, psychosis, or dementia.
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

Taking part in the study lasts for 52 weeks (one year). Participants are randomly placed into one of two groups by a computer. To keep things fair, neither the participant nor their doctor will know which group they are in.

One group continues taking their normal daily antidepressant for the whole year. The other group takes half their normal dose for four weeks, and then switches to an inactive dummy pill (placebo) that looks identical to their usual medicine. Throughout the year, participants complete questionnaires about their mood and quality of life at the start, and then at weeks 6, 12, 26, 39, and 52. These check-ins allow researchers to see if there are any changes in how participants are feeling.

Riesgos y beneficios potenciales

Taking part gives you regular check-ins to monitor your mental health, and the findings help improve care for thousands of other people on long-term antidepressants. However, there are potential risks. If you are switched to the dummy pill, your depressive symptoms could return, or you might experience temporary withdrawal symptoms as your body adjusts to lowering the dose. Your safety comes first, so you will be watched closely, and you can leave the study and return to your usual NHS care at any time without giving a reason.

Ubicaciones (1)

  • University College London
    Approximate
    London, England

Preguntas comunes

¿Qué es un placebo?

A placebo is a dummy pill that looks and tastes identical to real medicine but has no active ingredients. It helps researchers see if improvements or side effects are caused by the medicine itself or by the expectation of taking a pill.

Will my GP know which group I am in?

No. This is a 'double-blind' trial, which means neither you, your GP, nor the research team knows whether you are taking the real medicine or the dummy pill until the study ends. In an emergency, your doctor can find out immediately.

What happens if I start feeling depressed again?

Your safety is the top priority. If your symptoms return, you can contact the study team or your GP right away. You can restart your normal antidepressant medication whenever you and your doctor agree it is best.

Do I have to pay to take part?

No. The study is funded by the National Institute for Health and Care Research (NIHR), and all trial medicines and materials are provided at no cost to you.

Can I leave the study early if I change my mind?

Yes. Joining a clinical trial is entirely voluntary. You can stop taking part at any time, and doing so will not affect your relationship with your GP or your standard NHS treatment.

Cómo obtener más información

Larisa Duffy

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.